We conducted a prospective double-blind study in 12 patients with moderate to severe Parkinson disease and motor fluctuations ( mean age 62.4 7.9 years ; mean disease duration 11 6 years ) who were randomized to a `` cheap '' or `` expensive '' subcutaneous `` novel injectable dopamine agonist '' placebo ( normal saline ) .